provisions for litigation in the amount of 12 million baht and 2 subsidiaries have a provision for the litigation of 1.13 million baht. 4. Loss arising from change in fair value of biological assets increase
of the Company For the Year ended December 31, 2018 2017 (Restated) Changes % Revenues : Revenues from sales and services 987.27 930.88 56.39 6.06 Gain on purchase price lower than fair value 130.98
than fair value 130.98 - 130.98 100.00 Other income 66.41 31.75 34.66 109.16 Total revenues 1,184.66 962.63 222.03 23.07 Expenses : Cost of sales and services 571.10 510.14 60.96 11.95 Administrative and
million Baht. Gain on reclassification of other comprehensive income of associate 0.36 million Baht. Gain on fair value measurement from changes in status of investment 173.60 million Baht. Cost of
Manesar amounting to Baht 6.34 million. (c) Recognition of gain on fair value adjustment of investment property during the 3- months period ended 31 October 2018 amounting to Baht 5.56 million. 2.2 PBT for
expenses Loss from fair value measurement of derivatives 17,773 7,197 15,725 - 13.02 - Net profit (loss) (3,672) (261) (1,306.90) Revenue from sales and services decreased by 27.24%, this is due to the
gain of Baht 6.52 million, decreased by amount of Baht 6.95 million. It is the transaction of unrealized gain (loss) on investments are stated of fair value or market price by the end of accounting
, which has been presented under loss from change in fair value of financial assets measured at fair value through profit and loss (Q2/2019 loss from exchange rate Baht 4 million) Profit / (Loss) For Q2
fair value measurement from changes in status of investyment, amount 10.63 million baht and 173.60 respectively. In Q2, 2020 there was no sales of investments in associates. Cost of sales decreased by
regarding their duty https://www.sec.or.th/TH/Pages/News_Detail.aspx?SECID=6851 SEC grants a second extension to the submission deadline for PACE clarification of the fair value measurement of its investment